Intravenous administration of viral vectors expressing prostate cancer antigens enhances the magnitude and functionality of CD8+ T cell responses

por Vardeu, Antonella, Davis, Charlotte, McDonald, Ian, Stahlberg, Guilherme, Thapa, Barsha, Piotrowska, Kinga, Marshall, Margaret A, Evans, Thomas, Wheeler, Vicky, Sebastian, Sarah, Anderson, Katie
Publicado 2022

Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors

por Hong, David S., Rixe, Olivier, Chiu, Vi K., Forde, Patrick M., Dragovich, Tomislav, Lou, Yanyan, Nayak-Kapoor, Asha, Leidner, Rom, Atkins, James N., Collaku, Agron, Fox, Floyd E., Marshall, Margaret A., Olszanski, Anthony J.
Publicado 2022

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

por Ribas, Antoni, Chesney, Jason A, Gordon, Michael S, Abernethy, Amy P, Logan, Theodore F, Lawson, David H, Chmielowksi, Bartosz, Glaspy, John A, Lewis, Karl, Huang, Bo, Wang, Erjian, Hsyu, Poe-Hirr, Gomez-Navarro, Jesus, Gerhardt, Diana, Marshall, Margaret A, Gonzalez, Rene
Publicado 2012